Anavex Comments on New Alzheimer’s Disease Diagnostic Guidelines

Hoboken, NJ — May 17, 2011 — Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated for the first time in more than 25 years.  The new guidelines discuss…